- CRS Publications
- News
News
Authors:
Date:
PRNewswire: November 3, 2016 – SAN DIEGO, CA, U.S.A. – Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has accepted Genentech’s Biologics License Application for a subcutaneous formulation of rituximab in multiple blood cancer indications…
Authors:
Date:
PRNewswire: November 3, 2016 – WARRINGTON, PA, U.S.A. – Windtree Therapeutics, Inc. (Nasdaq: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, announced today that recently presented preclinical data at the 62nd Radiation Research…
Authors:
Date:
Business Wire: November 1, 2016 – SUNNYVALE, CA, U.S.A. – Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, today announced excellent six-month clinical data for the first 25-patient subset of the DESolve™ Cx Clinical…
Authors:
Date:
Business Wire: October 31, 2016 – JERUSALEM, Israel – Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, announced that the State Intellectual Property Office of the…
Authors:
Date:
PRNewswire: October 31, 2016 – DURHAM, NC, U.S.A. – Micell Technologies, Inc. (Micell) today announced that it presented five-year clinical safety and efficacy results from the DESSOLVE I and II trials of its MiStent sirolimus eluting absorbable polymer coronary stent system (MiStent® ). MiStent is…
Authors:
Date:
PRNewswire: October 31, 2016 – MISSISSAUGA, Ontario, Canada – Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), a global specialty pharmaceutical company, today announced that its subsidiary, Aralez Pharmaceuticals Trading DAC (Aralez Ireland), has completed its acquisition of the U.S. rights…
